Cubist Systematic Strategies’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,570
| Closed | -$388K | – | 2648 |
|
|
2019
Q4 | $388K | Sell |
4,570
-70,827
| -94% | -$4.72M | 0.01% | 1695 |
|
|
2019
Q3 | $3.77M | Buy |
75,397
+58,962
| +359% | +$2.35M | 0.07% | 385 |
|
|
2019
Q2 | $599K | Buy |
16,435
+16,235
| +8,118% | +$530K | 0.01% | 1363 |
|
|
2019
Q1 | $6K | Buy |
+200
| New | +$4.71K | ﹤0.01% | 2204 |
|
|
2018
Q4 | – | Sell |
-68,172
| Closed | -$2.04M | – | 2404 |
|
|
2018
Q3 | $2.04M | Buy |
+68,172
| New | +$2.57M | 0.11% | 209 |
|
|
2018
Q1 | – | Sell |
-9,821
| Closed | -$269K | – | 2184 |
|
|
2017
Q4 | $269K | Buy |
+9,821
| New | +$302K | 0.01% | 1331 |
|
|
2017
Q2 | – | Sell |
-135
| Closed | -$7K | – | 1978 |
|
|
2017
Q1 | $7K | Buy |
+135
| New | +$6.16K | ﹤0.01% | 1574 |
|
|
2016
Q4 | – | Sell |
-2,000
| Closed | -$75K | – | 1983 |
|
|
2016
Q3 | $75K | Buy |
2,000
+1,045
| +109% | +$39.4K | ﹤0.01% | 1519 |
|
|
2016
Q2 | $32K | Sell |
955
-2,297
| -71% | -$81K | ﹤0.01% | 1616 |
|
|
2016
Q1 | $103K | Sell |
3,252
-31,031
| -91% | -$1.01M | 0.01% | 1393 |
|
|
2015
Q4 | $1.28M | Buy |
34,283
+14,841
| +76% | +$561K | 0.07% | 364 |
|
|
2015
Q3 | $738K | Buy |
+19,442
| New | +$682K | 0.04% | 724 |
|
|
2015
Q2 | – | Sell |
-45,266
| Closed | -$1.27M | – | 2161 |
|
|
2015
Q1 | $1.27M | Buy |
45,266
+41,643
| +1,149% | +$1.17M | 0.06% | 458 |
|
|
2014
Q4 | $100K | Sell |
3,623
-30,976
| -90% | -$767K | 0.01% | 1697 |
|
|
2014
Q3 | $772K | Buy |
+34,599
| New | +$879K | 0.05% | 585 |
|
Other funds holding MDCO
Cubist Systematic Strategies's MDCO Position: Q1 2020 in Review
Cubist Systematic Strategies sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 4,570 shares — an estimated $388K sold.
Cubist Systematic Strategies first reported a position in MDCO in Q3 2014 and held it in 15 quarters. The position peaked at $3.77M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Cubist Systematic Strategies reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Cubist Systematic Strategies sold 4,570 Medicines Co shares in Q1 2020, an estimated $388K.
- Cubist Systematic Strategies first reported a position in Medicines Co in Q3 2014 and held it in 15 quarters.
- Cubist Systematic Strategies's Medicines Co position peaked at $3.77M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Cubist Systematic Strategies's 13F filing for Q1 2020, filed 15 May 2020.